4//SEC Filing
Morrison Scott W 4
Accession 0001610717-24-000342
CIK 0001626971other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:44 PM ET
Size
5.3 KB
Accession
0001610717-24-000342
Insider Transaction Report
Form 4
Morrison Scott W
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-13+15,000→ 15,000 totalExercise: $2.12Exp: 2034-06-13→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0001662426
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:44 PM ET
- Size
- 5.3 KB